Roy S. Herbst – författare
Visar alla böcker från författaren Roy S. Herbst. Handla med fri frakt och snabb leverans.
9 produkter
Lung Cancer, An Issue of Hematology/Oncology Clinics
Av Roy S. Herbst, Daniel Morgensztern
Inbunden, 2016
1091 kr
Lägg i varukorg
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant …
Antiangiogenic Cancer Therapy
Av Darren W. Davis, Roy S. Herbst m. fl.
Häftad, 2019
1069 kr
Lägg i varukorg
Top Investigators Explore the Complexities of Angiogenesis Cancer ResearchThe targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized …
Lung Cancer, An Issue of Hematology/Oncology Clinics of North America
Av Sarah B. Goldberg, Roy S. Herbst
Inbunden, 2023
1144 kr
Lägg i varukorg
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy …
Antiangiogenic Cancer Therapy
Av James L. Abbruzzese, Roy S. Herbst m. fl.
E-bok, 2007
1239 kr
Lägg i varukorg
Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a …
Antiangiogenic Cancer Therapy
Av James L. Abbruzzese, Roy S. Herbst m. fl.
E-bok, 2007
1266 kr
Lägg i varukorg
Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a …
Lung Cancer
New Understandings and Therapies
Av Anne C. Chiang, Roy S. Herbst
Inbunden, 2021
1688 kr
Lägg i varukorg
Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key …
Lung Cancer
New Understandings and Therapies
Av Roy S. Herbst, Anne C. Chiang
E-bok, 2021
1670 kr
Lägg i varukorg
Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key …
Lung Cancer
New Understandings and Therapies
Av Anne C. Chiang, Roy S. Herbst
Häftad, 2022
1240 kr
Lägg i varukorg
Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key …
Antiangiogenic Cancer Therapy
Av Darren W. Davis, Roy S. Herbst m. fl.
Inbunden, 2007
4666 kr
Tillfälligt slut
Top Investigators Explore the Complexities of Angiogenesis Cancer ResearchThe targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized …
